📋 Tender Overview
Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient Brivaracetam, ATC N03AX23 for the period September 1st, 2026 - August 31st, 2028 (plus extension option 1x12 months)